Fernand Labrie
Publications
Page 6 of 26, showing 50 records out of 1263 total, starting on record 251, ending on 300
| Publication | Category | Year |
|---|---|---|
| 258. Labrie, F., Dupont, A., Bélanger, A., St-Arnaud, R., Giguère, M., Lacourcière, Y., Emond, J., Monfette, G. (1986) Treatment of prostate cancer with gonadotropin-releasing hormone agonists. Endocrine Rev., 7: 67-74. | All publications | 1986 |
| 259. Labrie, F., Dupont, A., Emond, J., Monfette, G. (1986) Combination therapy in prostate cancer. Lancet, 2: 1095-1096. | All publications | 1986 |
| 260. Labrie, F., Dupont, A., Emond, J., Monfette, G. (1986) Combination therapy in prostate cancer. Br. Med. J. (Clin. Res. Ed.), 293: 1171. | All publications | 1986 |
| 261. Labrie, F., Dupont, A., Giguère, M., Borsanyi, A., Bélanger, A., Lacourcière, Y., Emond, J., Monfette, G. (1986) Advantages of the combination therapy in previously untreated and treated patients with advanced prostate cancer. J. Steroid Biochem., 25: 877-883. | All publications | 1986 |
| 262. Labrie, F., Veilleux, R. (1986) A wide range of sensitivities to androgens develops in cloned Shionogi mouse mammary tumor cells. Prostate, 8: 293-300. | All publications | 1986 |
| 263. Lacourcière, Y., Dupont, A., Giguère, M., Labrie, F. (1986) L'utilité de la scintigraphie osseuse dans l'évaluation de l'atteinte squelettique du cancer de la prostate traité à l'aide d'une association LHRH-antiandrogènes. Union Med. Can., 115: 229-234. | All publications | 1986 |
| 264. Poyet, P., Gagné, B., Labrie, F. (1986) Characteristics of the ?-adrenergic stimulation of adenylate cyclase activity in rat ventral prostate and its modulation by androgens. Prostate, 9: 237-245. | All publications | 1986 |
| 265. Poyet, P., Gagné, B., Lavoie, M., Labrie, F. (1986) Characteristics of the ?-adrenergic receptor in the rat ventral prostate using [125I]cyanopindolol. Mol. Cell. Endocrinol., 48: 59-67. | All publications | 1986 |
| 266. Raynaud, J.P., Coussedière, D., Moguilewsky, M., Pottier, J., Labrie, F. (1986) Cancer de la prostate: bases biologiques pour l'emploi d'un antiandrogène dans le traitement. Bulletin du Cancer, 73: 36-46. | All publications | 1986 |
| 267. Simard, J., Luthy, I., Guay, J., Bélanger, A., Labrie, F. (1986) Characteristics of interaction of the antiandrogen Flutamide with the androgen receptor in various target tissues. Mol. Cell. Endocrinol., 44: 261-270. | All publications | 1986 |
| 268. St-Arnaud, R., Lachance, R., Dupont, A., Labrie, F. (1986) Serum luteinizing hormone (LH) biological activity in castrated patients with cancer of the prostate receiving a pure antiandrogen and in estrogen-treated patients treated with an LH-releasing hormone agonist and antiandrogen. J. Clin. Endocrinol. Metab., 63: 297-302. | All publications | 1986 |
| 269. St-Arnaud, R., Lachance, R., Dupont, A., Labrie, F. (1986) Stimulation of the circulating levels of glycoprotein hormone alpha-subunit after combined administration of a luteinizing hormone-releasing hormone (LHRH) agonist and Flutamide in patients with cancer of the prostate. Clin. Invest. Med., 9: 215-221. | All publications | 1986 |
| 270. St-Arnaud, R., Lachance, R., Kelly, S.J., Bélanger, A., Dupont, A., Labrie, F. (1986) Loss of luteinizing hormone (LH) bioactivity in patients with prostatic cancer treated with an LHRH agonist and a pure antiandrogen. Clin. Endocrinol. (Oxf.), 24: 21-30. | All publications | 1986 |
| 271. Labrie, F. (1985) Dreijahrige erfahrungen mit der Kombinations-therapie von Flutamid und einem LHRH-agonisten leuprolide beim Prostatakarzinom. Der Urologe. Ausg. B., B6: 342-343. | All publications | 1985 |
| 272. Labrie, F. (1985) LHRH et ses agonistes: applications thérapeutiques. Médecine/Sciences, 1: 300-305. | All publications | 1985 |
| 273. Labrie, F., Dupont, A., Bélanger, A. (1985) Complete androgen blockade for the treatment of prostate cancer, in: DeVita, V.T., Hellman, S. et Rosenberg, S.A., eds: Important Advances in Oncology, Philadelphia, J.B. Lippincott, pp 193-217. | All publications | 1985 |
| 274. Labrie, F., Dupont, A., Bélanger, A., Giguère, M., Lacourcière, Y., Emond, J., Monfette, G., Bergeron, V. (1985) Combination therapy with Flutamide and castration (LHRH agonist or orchiectomy) in advanced prostate cancer: a marked improvement in response and survival. J. Steroid Biochem., 23: 833-841. | All publications | 1985 |
| 275. Labrie, F., Dupont, A., Bélanger, A., Lachance, R., Giguère, M. (1985) Long-term treatment with luteinizing hormone-releasing hormone agonists and maintenance of serum testosterone to castration concentrations. Br. Med. J. (Clin. Res. Ed.), 291: 369-370. | All publications | 1985 |
| 276. Labrie, F., Dupont, A., Bélanger, A., Lacourcière, Y., Emond, J., Monfette, G., Bergeron, V. (1985) Antiandrogènes et agonistes de la LHRH dans le traitement du cancer de la prostate. Médecine/Sciences, 1: 435-439. | All publications | 1985 |
| 277. Perez, C.A., Fair, W.R., Ihde, D.C., Labrie, F. (1985) Cancer of the prostate, in: De Vita, V.T., Hellman, S. et Rosenberg, C., eds: Cancer: Principles and Practice of Oncology, Philadelphia, J.P. Lippincott, pp 929-964. | All publications | 1985 |
| 278. Poyet, P., Labrie, F. (1985) Comparison of the antiandrogenic/androgenic activities of flutamide, cyproterone acetate and megestrol acetate. Mol. Cell. Endocrinol., 42: 283-288. | All publications | 1985 |
| 279. Raynaud, J.P., Moguilewsky, M., Tournemine, C., Pottier, J., Coussedière, D., Salmon, J., Husson, J.M., Bertagna, C., Tremblay, D., Pendyala, L., Brisset, J.M., Vallancien, G., Serment, G., Navratil, N., Dupont, A., Labrie, F. (1985) Pharmacology and clinical studies with RU23908 (Anandron). EORTC Genitourinary Group Monograph 2, Part A, in: Schroeder, F.H. et Richards, B., eds: Therapeutic Principles Metastatic Protastic Cancer, New York, Alan R. Liss Inc., pp 99-120. | All publications | 1985 |
| 280. Bélanger, A., Dupont, A., Labrie, F. (1984) Inhibition of basal and adrenocorticotropin-stimulated plasma levels of adrenal androgens after treatment with an antiandrogen in castrated patients with prostatic cancer. J. Clin. Endocrinol. Metab., 59: 422-426. | All publications | 1984 |
| 281. Bélanger, A., Tremblay, Y., Lacoste, D., Giasson, M., Dupont, A., Labrie, F. (1984) The dog, a good model for the study of LHRH agonists as blockers of androgen secretion and potential contraceptives, in: Labrie, F., Bélanger, A. et Dupont, A., eds: Proceedings of the International Symposium on LHRH and its Analogues: Basic and Clinical Aspects, New York, Excerpta Medica, pp 141-155. | All publications | 1984 |
| 282. Faure, N., Lemay, A., Tolis, G., Labrie, F., Bélanger, A., Fazekas, A.T.A. (1984) Buserelin therapy for prostatic carcinoma, in: Vickery, B.H., Nestor, J.J. et Hafez, E.S.E., eds: LHRH and its analogs: contraceptive and therapeutic applications, Boston, MTP Press, pp 337-349. | All publications | 1984 |
| 283. Labrie, F. (1984) A new approach in the hormonal treatment of prostate cancer: complete instead of partial blockade of androgens. Int. J. Androl., 7: 1-4. | All publications | 1984 |
| 284. Labrie, F. (1984) Résultats exceptionnels d'un nouveau traitement du cancer de la prostate. Interface, 5: 23-25. | All publications | 1984 |
| 285. Labrie, F., Bélanger, A., Dupont, A., Emond, J., Lacourcière, Y., Monfette, G. (1984) Combined treatment with an LHRH agonist and a pure antiandrogen in advanced carcinoma of prostate. Lancet, 2: 1090. | All publications | 1984 |
| 286. Labrie, F., Bélanger, A., Dupont, A., St-Arnaud, R. (1984) Medical castration in men: the first clinical application of LHRH agonists, in: Harrison, R.F. et Thompson, B.J., eds: Fertility and Sterility, MTP Press, pp 25-39. | All publications | 1984 |
| 287. Labrie, F., Dupont, A., Bélanger, A. (1984) Complete androgen neutralization is most important in the treatment of prostate cancer, in: Harrap, K.R., Davis, W. et Calvert, A.H., eds: Cancer Chemotherapy and Selective Drug Development, Martinus Nijihoff Publishing, pp 475-479. | All publications | 1984 |
| 288. Labrie, F., Dupont, A., Bélanger, A. (1984) Un nouveau traitement du cancer de la prostate: la suppression complète des androgènes, in: Mauvais-Jarvis, P. et Schaison, G., eds: Médecine de la reproduction masculine, Flammarion, Presses Université de Montréal, pp 367-383. | All publications | 1984 |
| 289. Labrie, F., Dupont, A., Bélanger, A., Emond, J., Monfette, G. (1984) Simultaneous administration of pure antiandrogens, a combination necessary for the use of luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer. Proc. Natl. Acad. Sci. USA, 81: 3861-3863. | All publications | 1984 |
| 290. Labrie, F., Dupont, A., Bélanger, A., Labrie, C., Lacourcière, Y., Emond, J., Monfette, G., Houle, J.G., Girard, J.G., Vallières, A., Bossé, C., Delisle, R. (1984) Dramatic response of prostate cancer to complete antihormonal treatment, in: Bracci, U. et Silverio, F.D., eds: Advances in Urological Oncology and Endocrinology, Rome, Acta Medica, Edizione E Congressi, pp 233-248. | All publications | 1984 |
| 291. Labrie, F., Dupont, A., Bélanger, A., Labrie, C., Lacourcière, Y., Raynaud, J.P., Husson, J.M., Emond, J., Houle, J.G., Girard, J.G., Monfette, G., Paquet, J.P., Vallières, A., Bossé, C., Delisle, R. (1984) Combined antihormonal treatment in prostate cancer: a new approach using an LHRH agonist or castration and an antiandrogen, in: Bresciani, F., King, R.J.B., Lippman, M.E. et Raynaud, J.P., eds: Hormones and cancer 2: Proceedings of the Second International Congress on Hormones and Cancer, New York, Raven Press, pp 533-547. | All publications | 1984 |
| 292. Labrie, F., Dupont, A., Bélanger, A., Lacourcière, Y., Emond, J., Monfette, G. (1984) Combined antiandrogen blockade in adenocarcinoma of the prostate: the first application of a successful new therapeutic principle in hormone-dependent cancer, in: Arvis, G., ed. Second International Forum on Andrology, Expansion Scientifique Française, Paris, pp 163-196. | All publications | 1984 |
| 293. Labrie, F., Dupont, A., Bélanger, A., Lacourcière, Y., Members of LUPCP. (1984) Complete androgen blockade at start of treatment causes a dramatic improvement of survival in advanced prostate cancer, in: Labrie, F., Bélanger, A. et Dupont, A., eds: Proceedings of the International Symposium on LHRH and its analogues: Basic and Clinical Aspects, Excerpta Medica, pp 368-379. | All publications | 1984 |
| 294. Labrie, F., Dupont, A., Bélanger, A., Members of LUPCP (1984) Spectacular response to combined antihormonal treatment in advanced prostate cancer, in: Labrie, F. et Proulx, L., eds: Endocrinology ICS 655, Excerpta Medica, pp 450-453. | All publications | 1984 |
| 295. Labrie, F., Dupont, A., Bélanger, A., St-Arnaud, R., Labrie, C., Members of LUPCP (1984) Medical castration with LHRH agonists and the need for combined treatment with an antiandrogen in prostate cancer, in: McKerns, K.W., ed. Hormonal Control of the Hypothalamic-Pituitary Gonadal Axis, New York, Plenum Press, pp 531-549. | All publications | 1984 |
| 296. Labrie, F., Tremblay, Y., Bélanger, A., Dupont, A. (1984) Medical castration is easily achieved with LHRH agonists, in: Scierra, J.J., ed. 5th International Meeting on Fertility Control, Genoa, Italy, pp 49-60. | All publications | 1984 |
| 297. Lefebvre, F.A., Bélanger, A., Pelletier, G., Labrie, F. (1984) Recovery of gonadal functions in the adult male rat following cessation of 5-month daily treatment with an LHRH agonist. J. Androl., 5: 181-192. | All publications | 1984 |
| 298. Marchetti, B., Labrie, F. (1984) Further characterization of the direct inhibitory effect of LHRH agonists at the testicular level in the rat. J. Steroid Biochem., 20: 339-342. | All publications | 1984 |
| 299. Raynaud, J.P., Bonne, C., Moguilewsky, M., Lefebvre, F.A., Bélanger, A., Labrie, F. (1984) The pure antiandrogen, RU23908 (Anandron), a candidate of choice for the combined antihormonal treatment of prostatic cancer: a review. Prostate, 5: 299-311. | All publications | 1984 |
| 300. Tremblay, Y., Bélanger, A., Labrie, F., Frenette, G., Dubé, J.Y., Tremblay, R.R. (1984) Characteristics of the inhibitory effect of chronic treatment with an LHRH agonist on testicular steroidogenesis in the dog. Prostate, 5: 631-638. | All publications | 1984 |
| 301. Tremblay, Y., Bélanger, A., Lacoste, D., Giasson, M., Labrie, F. (1984) Selective inhibition of spermatogenesis in the presence of normal libido following combined treatment with an LHRH agonist and testosterone in the dog. Contraception, 30: 585-598. | All publications | 1984 |
| 302. Bélanger, A., Labrie, F., Séguin, C., Cusan, L., Carmichael, R., Caron, S. (1983) Inhibition of testicular delta 4-androgen secretion in the rat by treatment with luteinizing hormone-releasing hormone, in: Negro-Vilar, A., ed. Male Reproduction and Fertility, New York, Raven Press, pp 127-139. | All publications | 1983 |
| 303. Labrie, F. (1983) A new therapy in prostatic cancer. Urology Times, August. | All publications | 1983 |
| 304. Labrie, F. (1983) Luteinizing hormone-releasing hormone agonists and fertility regulation. The 9th Jennifer Hallam Memorial Lecture. J. Obst. Gynecol., 3: S37-S46. | All publications | 1983 |
| 305. Labrie, F., Bélanger, A., Carmichael, R., Séguin, C., Lefebvre, F.A., Faure, N., Dupont, A. (1983) Inhibition of the testicular steroidogenic pathway in experimental animals and men, in: D'Agata, R., Lipsett, M.B.,Polosa, P. et van der Molen, H.J., eds: Recent Advances in Male Reproduction: Molecular Basis and Clinical Implications, New York, Raven Press, pp 239-248. | All publications | 1983 |
| 306. Labrie, F., Dupont, A., Bélanger, A., Husson, J.M., Raynaud, J.P. (1983) Nouveau traitement antihormonal avec un antiandrogène et un agoniste de la LHRH dans le cancer de la prostate. Ann. Endocrinol. (Paris), 44: 343-344. | All publications | 1983 |
| 307. Labrie, F., Dupont, A., Bélanger, A., Lacourcière, Y., Raynaud, J.P., Husson, J.M., Gareau, J., Fazekas, A.T.A., Sandow, J., Monfette, G. (1983) New approach in the treatment of prostate cancer: complete instead of only partial withdrawal of androgens. Prostate, 4: 579-594. | All publications | 1983 |